Bibliographic Details
| Title: |
Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders. |
| Authors: |
Teixeira, Maria de Lourdes Benamor, Costa Ferreira Júnior, Orlando da, João, Esaú, Fuller, Trevon, Silva Esteves, Juliana, Mendes-Silva, Wallace, Carvalho Mocarzel, Carolina, Araújo Maia, Richard, Theodoro Boullosa, Lídia, Gonçalves, Cássia Cristina Alves, Frankel, Patrícia Pontes, Fragoso da Silveira Gouvêa, Maria Isabel |
| Source: |
Viruses (1999-4915); Jul2021, Vol. 13 Issue 7, p1277-1277, 1p |
| Subject Terms: |
COVID-19, PREGNANT women, SARS-CoV-2, LOW-income countries, MIDDLE-income countries, COMORBIDITY |
| Abstract: |
There are some reports and case series addressing Coronavirus Disease 2019 (COVID-19) infections during pregnancy in upper income countries, but there are few data on pregnant women with comorbid conditions in low and middle income Countries. This study evaluated the proportion and the maternal and neonatal outcomes associated with SARS-CoV-2 infection among pregnant women with comorbidities. Participants were recruited consecutively in order of admission to a maternity for pregnant women with comorbidities. Sociodemographic, clinical, and laboratory data were prospectively collected during hospitalization. Pregnant women were screened at entry: nasopharyngeal swabs were tested by RT-PCR; serum samples were tested for IgG antibodies against spike protein by ELISA. From April to June 2020, 115 eligible women were included in the study. The proportion of SARS-CoV-2 infection was 28.7%. The rate of obesity was 60.9%, vascular hypertension 40.0%, and HIV 21.7%. The most common clinical presentations were ageusia (21.2%), anosmia (18.2%), and fever (18.2%). Prematurity was higher among mothers who had a SARS-CoV-2 infection based on RT-PCR. There were two cases of fetal demise. We found a high proportion of COVID-19 among pregnant women with comorbidities. This underscores the importance of antenatal care during the pandemic to implement universal SARS-CoV-2 screening, precautionary measures, and the rollout of vaccination programs for pregnant women. [ABSTRACT FROM AUTHOR] |
|
Copyright of Viruses (1999-4915) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
|
Full text is not displayed to guests. |
Login for full access.
|
